| Type |
Details |
Score |
| Publication |
| First Author: |
Karalis V |
| Year: |
2022 |
| Journal: |
Nat Commun |
| Title: |
Raptor downregulation rescues neuronal phenotypes in mouse models of Tuberous Sclerosis Complex. |
| Volume: |
13 |
| Issue: |
1 |
| Pages: |
4665 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Goel S |
| Year: |
2016 |
| Journal: |
Cancer Cell |
| Title: |
Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors. |
| Volume: |
29 |
| Issue: |
3 |
| Pages: |
255-269 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yamaguchi S |
| Year: |
2021 |
| Journal: |
Front Endocrinol (Lausanne) |
| Title: |
Adipocyte-Specific Inhibition of Mir221/222 Ameliorates Diet-Induced Obesity Through Targeting Ddit4. |
| Volume: |
12 |
|
| Pages: |
750261 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
H?usl AS |
| Year: |
2022 |
| Journal: |
Sci Adv |
| Title: |
Mediobasal hypothalamic FKBP51 acts as a molecular switch linking autophagy to whole-body metabolism. |
| Volume: |
8 |
| Issue: |
10 |
| Pages: |
eabi4797 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang W |
| Year: |
2023 |
| Journal: |
Nat Commun |
| Title: |
Cytoplasmic Endonuclease G promotes nonalcoholic fatty liver disease via mTORC2-AKT-ACLY and endoplasmic reticulum stress. |
| Volume: |
14 |
| Issue: |
1 |
| Pages: |
6201 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Yeung RS |
| Year: |
1994 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. |
| Volume: |
91 |
| Issue: |
24 |
| Pages: |
11413-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kobayashi T |
| Year: |
1995 |
| Journal: |
Nat Genet |
| Title: |
A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. |
| Volume: |
9 |
| Issue: |
1 |
| Pages: |
70-4 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Geist RT |
| Year: |
1995 |
| Journal: |
Cell Growth Differ |
| Title: |
The tuberous sclerosis 2 gene is expressed at high levels in the cerebellum and developing spinal cord. |
| Volume: |
6 |
| Issue: |
11 |
| Pages: |
1477-83 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kobayashi T |
| Year: |
1997 |
| Journal: |
Mamm Genome |
| Title: |
Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog. |
| Volume: |
8 |
| Issue: |
8 |
| Pages: |
554-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Faubert B |
| Year: |
2015 |
| Journal: |
Cancer Lett |
| Title: |
The AMP-activated protein kinase (AMPK) and cancer: many faces of a metabolic regulator. |
| Volume: |
356 |
| Issue: |
2 Pt A |
| Pages: |
165-70 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Bartolom? A |
| Year: |
2017 |
| Journal: |
Mol Cell Biol |
| Title: |
MTORC1 Regulates both General Autophagy and Mitophagy Induction after Oxidative Phosphorylation Uncoupling. |
| Volume: |
37 |
| Issue: |
23 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lozovaya N |
| Year: |
2014 |
| Journal: |
Nat Commun |
| Title: |
Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. |
| Volume: |
5 |
|
| Pages: |
4563 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Byun JK |
| Year: |
2019 |
| Journal: |
EMBO Rep |
| Title: |
Oncogenic KRAS signaling activates mTORC1 through COUP-TFII-mediated lactate production. |
| Volume: |
20 |
| Issue: |
6 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Sancak Y |
| Year: |
2007 |
| Journal: |
Mol Cell |
| Title: |
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. |
| Volume: |
25 |
| Issue: |
6 |
| Pages: |
903-15 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hong F |
| Year: |
2008 |
| Journal: |
Mol Cell |
| Title: |
mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. |
| Volume: |
30 |
| Issue: |
6 |
| Pages: |
701-11 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1814
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1785
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1808
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1741
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1742
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1742
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1785
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1678
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1808
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
1742
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
621
 |
| Fragment?: |
false |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xiao GH |
| Year: |
1997 |
| Journal: |
J Biol Chem |
| Title: |
The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. |
| Volume: |
272 |
| Issue: |
10 |
| Pages: |
6097-100 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kurbegovic A |
| Year: |
2014 |
| Journal: |
Mol Cell Biol |
| Title: |
Novel functional complexity of polycystin-1 by GPS cleavage in vivo: role in polycystic kidney disease. |
| Volume: |
34 |
| Issue: |
17 |
| Pages: |
3341-53 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Xu G |
| Year: |
2015 |
| Journal: |
Diabetologia |
| Title: |
Intestinal mTOR regulates GLP-1 production in mouse L cells. |
| Volume: |
58 |
| Issue: |
8 |
| Pages: |
1887-97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhou J |
| Year: |
2009 |
| Journal: |
Hum Mol Genet |
| Title: |
Loss of Tsc1, but not Pten, in renal tubular cells causes polycystic kidney disease by activating mTORC1. |
| Volume: |
18 |
| Issue: |
22 |
| Pages: |
4428-41 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Guo Y |
| Year: |
2014 |
| Journal: |
Oncogene |
| Title: |
Tsc1-Tp53 loss induces mesothelioma in mice, and evidence for this mechanism in human mesothelioma. |
| Volume: |
33 |
| Issue: |
24 |
| Pages: |
3151-60 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang J |
| Year: |
2022 |
| Journal: |
Cell Signal |
| Title: |
LysM-positive neurons drive Tuberous Sclerosis Complex (TSC)-associated brain lesions. |
| Volume: |
100 |
|
| Pages: |
110468 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Barone S |
| Year: |
2021 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Kidney intercalated cells and the transcription factor FOXi1 drive cystogenesis in tuberous sclerosis complex. |
| Volume: |
118 |
| Issue: |
6 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Namikawa M |
| Year: |
2023 |
| Journal: |
J Pathol |
| Title: |
Simultaneous activation of Kras-Akt and Notch pathways induces extrahepatic biliary cancer via the mTORC1 pathway. |
| Volume: |
260 |
| Issue: |
4 |
| Pages: |
478-492 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Meikle L |
| Year: |
2008 |
| Journal: |
J Neurosci |
| Title: |
Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. |
| Volume: |
28 |
| Issue: |
21 |
| Pages: |
5422-32 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Hu Z |
| Year: |
2015 |
| Journal: |
J Biol Chem |
| Title: |
Brain-expressed X-linked 2 Is Pivotal for Hyperactive Mechanistic Target of Rapamycin (mTOR)-mediated Tumorigenesis. |
| Volume: |
290 |
| Issue: |
42 |
| Pages: |
25756-65 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mori H |
| Year: |
2009 |
| Journal: |
Am J Physiol Endocrinol Metab |
| Title: |
Critical roles for the TSC-mTOR pathway in ?-cell function. |
| Volume: |
297 |
| Issue: |
5 |
| Pages: |
E1013-22 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wilson C |
| Year: |
2006 |
| Journal: |
Cancer Res |
| Title: |
Tsc1 haploinsufficiency without mammalian target of rapamycin activation is sufficient for renal cyst formation in Tsc1+/- mice. |
| Volume: |
66 |
| Issue: |
16 |
| Pages: |
7934-8 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Feliciano DM |
| Year: |
2011 |
| Journal: |
J Clin Invest |
| Title: |
Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. |
| Volume: |
121 |
| Issue: |
4 |
| Pages: |
1596-607 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wei Z |
| Year: |
2021 |
| Journal: |
FASEB J |
| Title: |
Death-associated protein kinase 1 (DAPK1) controls CD8(+) T cell activation, trafficking, and antitumor activity. |
| Volume: |
35 |
| Issue: |
1 |
| Pages: |
e21138 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liang MC |
| Year: |
2010 |
| Journal: |
Oncogene |
| Title: |
TSC1 loss synergizes with KRAS activation in lung cancer development in the mouse and confers rapamycin sensitivity. |
| Volume: |
29 |
| Issue: |
11 |
| Pages: |
1588-97 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wang M |
| Year: |
2026 |
| Journal: |
Cancer Discov |
| Title: |
p53 Drives Lung Cancer Regression through a TSC2/TFEB-dependent Senescence Program. |
| Volume: |
16 |
| Issue: |
2 |
| Pages: |
391-411 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Meikle L |
| Year: |
2005 |
| Journal: |
Hum Mol Genet |
| Title: |
A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes. |
| Volume: |
14 |
| Issue: |
3 |
| Pages: |
429-35 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wilson C |
| Year: |
2005 |
| Journal: |
Hum Mol Genet |
| Title: |
A mouse model of tuberous sclerosis 1 showing background specific early post-natal mortality and metastatic renal cell carcinoma. |
| Volume: |
14 |
| Issue: |
13 |
| Pages: |
1839-50 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Carson RP |
| Year: |
2013 |
| Journal: |
Hum Mol Genet |
| Title: |
Deletion of Rictor in neural progenitor cells reveals contributions of mTORC2 signaling to tuberous sclerosis complex. |
| Volume: |
22 |
| Issue: |
1 |
| Pages: |
140-52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Armour EA |
| Year: |
2012 |
| Journal: |
Am J Physiol Renal Physiol |
| Title: |
Cystogenesis and elongated primary cilia in Tsc1-deficient distal convoluted tubules. |
| Volume: |
303 |
| Issue: |
4 |
| Pages: |
F584-92 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Pilipow K |
| Year: |
2014 |
| Journal: |
PLoS One |
| Title: |
Monoallelic germline TSC1 mutations are permissive for T lymphocyte development and homeostasis in tuberous sclerosis complex individuals. |
| Volume: |
9 |
| Issue: |
3 |
| Pages: |
e91952 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lu Q |
| Year: |
2019 |
| Journal: |
Acta Pharmacol Sin |
| Title: |
Inactivation of TSC1 promotes epithelial-mesenchymal transition of renal tubular epithelial cells in mouse diabetic nephropathy. |
| Volume: |
40 |
| Issue: |
12 |
| Pages: |
1555-1567 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fang Y |
| Year: |
2020 |
| Journal: |
Cell Death Discov |
| Title: |
Metformin effectively treats Tsc1 deletion-caused kidney pathology by upregulating AMPK phosphorylation. |
| Volume: |
6 |
|
| Pages: |
52 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Jones I |
| Year: |
2015 |
| Journal: |
Dis Model Mech |
| Title: |
A novel mouse model of tuberous sclerosis complex (TSC): eye-specific Tsc1-ablation disrupts visual-pathway development. |
| Volume: |
8 |
| Issue: |
12 |
| Pages: |
1517-29 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Wundrach D |
| Year: |
2020 |
| Journal: |
Front Mol Neurosci |
| Title: |
A Human TSC1 Variant Screening Platform in Gabaergic Cortical Interneurons for Genotype to Phenotype Assessments. |
| Volume: |
13 |
|
| Pages: |
573409 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Britto FA |
| Year: |
2014 |
| Journal: |
Am J Physiol Endocrinol Metab |
| Title: |
REDD1 deletion prevents dexamethasone-induced skeletal muscle atrophy. |
| Volume: |
307 |
| Issue: |
11 |
| Pages: |
E983-93 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Steiner JL |
| Year: |
2015 |
| Journal: |
Am J Physiol Endocrinol Metab |
| Title: |
Disruption of REDD1 gene ameliorates sepsis-induced decrease in mTORC1 signaling but has divergent effects on proteolytic signaling in skeletal muscle. |
| Volume: |
309 |
| Issue: |
12 |
| Pages: |
E981-94 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kim SH |
| Year: |
2017 |
| Journal: |
Autophagy |
| Title: |
Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. |
| Volume: |
13 |
| Issue: |
10 |
| Pages: |
1767-1781 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Chung DC |
| Year: |
1998 |
| Journal: |
Cancer Res |
| Title: |
Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors. |
| Volume: |
58 |
| Issue: |
16 |
| Pages: |
3706-11 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Rennebeck G |
| Year: |
1998 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryonic lethality characterized by disrupted neuroepithelial growth and development. |
| Volume: |
95 |
| Issue: |
26 |
| Pages: |
15629-34 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Satake N |
| Year: |
1999 |
| Journal: |
Cancer Res |
| Title: |
Isolation and characterization of a rat homologue of the human tuberous sclerosis 1 gene (Tsc1) and analysis of its mutations in rat renal carcinomas. |
| Volume: |
59 |
| Issue: |
4 |
| Pages: |
849-55 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cai S |
| Year: |
2003 |
| Journal: |
Am J Pathol |
| Title: |
Polycystic kidney disease as a result of loss of the tuberous sclerosis 2 tumor suppressor gene during development. |
| Volume: |
162 |
| Issue: |
2 |
| Pages: |
457-68 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Dan HC |
| Year: |
2008 |
| Journal: |
J Immunol |
| Title: |
Differential involvement of IkappaB kinases alpha and beta in cytokine- and insulin-induced mammalian target of rapamycin activation determined by Akt. |
| Volume: |
180 |
| Issue: |
11 |
| Pages: |
7582-9 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Tyryshkin A |
| Year: |
2014 |
| Journal: |
Cancer Res |
| Title: |
SRC kinase is a novel therapeutic target in lymphangioleiomyomatosis. |
| Volume: |
74 |
| Issue: |
7 |
| Pages: |
1996-2005 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Le K |
| Year: |
2018 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Effect of beta-agonists on LAM progression and treatment. |
| Volume: |
115 |
| Issue: |
5 |
| Pages: |
E944-E953 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Radhakrishnan VM |
| Year: |
2010 |
| Journal: |
PLoS One |
| Title: |
14-3-3gamma induces oncogenic transformation by stimulating MAP kinase and PI3K signaling. |
| Volume: |
5 |
| Issue: |
7 |
| Pages: |
e11433 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Steagall WK |
| Year: |
2018 |
| Journal: |
Am J Respir Cell Mol Biol |
| Title: |
The Lymphangioleiomyomatosis Lung Cell and Its Human Cell Models. |
| Volume: |
58 |
| Issue: |
6 |
| Pages: |
678-683 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lai M |
| Year: |
2021 |
| Journal: |
Proc Natl Acad Sci U S A |
| Title: |
Tsc1 regulates tight junction independent of mTORC1. |
| Volume: |
118 |
| Issue: |
30 |
|
|
•
•
•
•
•
|
| Publication |
| First Author: |
Koike-Kumagai M |
| Year: |
2022 |
| Journal: |
Neuropharmacology |
| Title: |
Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice. |
| Volume: |
218 |
|
| Pages: |
109203 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Shah OJ |
| Year: |
2004 |
| Journal: |
Curr Biol |
| Title: |
Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. |
| Volume: |
14 |
| Issue: |
18 |
| Pages: |
1650-6 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Kong SW |
| Year: |
2014 |
| Journal: |
Mol Autism |
| Title: |
Divergent dysregulation of gene expression in murine models of fragile X syndrome and tuberous sclerosis. |
| Volume: |
5 |
| Issue: |
1 |
| Pages: |
16 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Fan W |
| Year: |
2017 |
| Journal: |
Free Radic Biol Med |
| Title: |
Endothelial deletion of mTORC1 protects against hindlimb ischemia in diabetic mice via activation of autophagy, attenuation of oxidative stress and alleviation of inflammation. |
| Volume: |
108 |
|
| Pages: |
725-740 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Nie D |
| Year: |
2015 |
| Journal: |
J Neurosci |
| Title: |
The Stress-Induced Atf3-Gelsolin Cascade Underlies Dendritic Spine Deficits in Neuronal Models of Tuberous Sclerosis Complex. |
| Volume: |
35 |
| Issue: |
30 |
| Pages: |
10762-72 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
McLane LE |
| Year: |
2017 |
| Journal: |
J Neurosci |
| Title: |
Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination. |
| Volume: |
37 |
| Issue: |
31 |
| Pages: |
7534-7546 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Cox RL |
| Year: |
2018 |
| Journal: |
Front Mol Neurosci |
| Title: |
Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain. |
| Volume: |
11 |
|
| Pages: |
409 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Haji N |
| Year: |
2020 |
| Journal: |
Mol Autism |
| Title: |
Tsc1 haploinsufficiency in Nkx2.1 cells upregulates hippocampal interneuron mTORC1 activity, impairs pyramidal cell synaptic inhibition, and alters contextual fear discrimination and spatial working memory in mice. |
| Volume: |
11 |
| Issue: |
1 |
| Pages: |
29 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zou J |
| Year: |
2017 |
| Journal: |
Epilepsia |
| Title: |
Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner. |
| Volume: |
58 |
| Issue: |
12 |
| Pages: |
2053-2063 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Mashimo T |
| Year: |
2009 |
| Journal: |
PLoS Genet |
| Title: |
Progressive Purkinje cell degeneration in tambaleante mutant mice is a consequence of a missense mutation in HERC1 E3 ubiquitin ligase. |
| Volume: |
5 |
| Issue: |
12 |
| Pages: |
e1000784 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Lee Y |
| Year: |
2017 |
| Journal: |
Front Mol Neurosci |
| Title: |
Striatal Transcriptome and Interactome Analysis of Shank3-overexpressing Mice Reveals the Connectivity between Shank3 and mTORC1 Signaling. |
| Volume: |
10 |
|
| Pages: |
201 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Zhang Y |
| Year: |
2017 |
| Journal: |
Biochim Biophys Acta Mol Basis Dis |
| Title: |
Complex inhibition of autophagy by mitochondrial aldehyde dehydrogenase shortens lifespan and exacerbates cardiac aging. |
| Volume: |
1863 |
| Issue: |
8 |
| Pages: |
1919-1932 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Soleimani M |
| Year: |
2023 |
| Journal: |
Front Physiol |
| Title: |
Not all kidney cysts are created equal: a distinct renal cystogenic mechanism in tuberous sclerosis complex (TSC). |
| Volume: |
14 |
|
| Pages: |
1289388 |
|
•
•
•
•
•
|
| Publication |
| First Author: |
Liu W |
| Year: |
2019 |
| Journal: |
BMC Complement Altern Med |
| Title: |
Weipiling ameliorates gastric precancerous lesions in Atp4a(-/-) mice. |
| Volume: |
19 |
| Issue: |
1 |
| Pages: |
318 |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
367
 |
| Fragment?: |
true |
|
•
•
•
•
•
|
| Protein |
| Organism: |
Mus musculus/domesticus |
| Length: |
4859
 |
| Fragment?: |
false |
|
•
•
•
•
•
|